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DEXA Dual-Energy X-Ray Absorptiometry 
 
eGFR Estimated Glomerular Filtration Rate
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Hospital Anxiety and Depression Scale 
HR Heart Rate 
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High-Sensitivity C-Reactive Protein 
Hb 
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KTRs 
 
Kidney Transplant Recipients 
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MFI-20 Multi-Dimensional Fatigue Inventory-20 
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New-Onset Diabetes After Transplantation 
O2 pulse Oxygen Pulse 
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RPEindex 
 
Rating of Perceived Exertion Index 
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Abstract 
Background:  Physical fatigue is debilitating and common among kidney transplant 
recipients (KTRs).  This study investigated the mechanistic aetiology of physical fatigue in 
this setting through examinations of muscle mass, muscular and cardiovascular function, and 
perceived exertion.  The incidence of physical fatigue, its association with quality of life 
(QoL), and the predictors of perceived exertion, were evaluated.   
Methods:  This single-centre observational cross-sectional study enrolled 55 KTRs.  Muscle 
mass was quantified using dual-energy x-ray absorptiometry.  Muscular function was 
assessed by jumping mechanography.  Cardiovascular function (maximal oxygen 
consumption and oxygen pulse) was estimated during submaximal exercise testing, with 
perceived exertion determined using age-adjusted Borg scale-ratings.  Physical fatigue was 
measured using Multi-Dimensional Fatigue Inventory-20.  QoL was assessed using Medical 
Outcomes Study Short Form-36.  Demographic, clinical, nutritional, psychosocial and 
behavioural predictors of perceived exertion were assessed.   
Results:  Of clinical importance, increased perceived exertion was the only independent 
predictor of physical fatigue (p=0.001), with no association found between physical fatigue 
and muscular or cardiovascular parameters.  Physical fatigue occurred in 22% of KTRs, and 
negatively impacted on QoL (p<0.001).  Predictors of heightened perception included anxiety 
(p<0.05) and mental fatigue (p<0.05). 
Conclusion:  Perception is a key determinant of physical fatigue in KTRs, paving the way for 
future interventions. 
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Introduction 
Fatigue is the subjective sensation of profound and persistent tiredness, weakness, and lack of 
energy (1, 2).  It is a complex and multi-dimensional phenomenon involving physical, 
cognitive, and emotional components that interfere with individuals’ abilities to function 
normally (2, 3).  Fatigue is a prevalent patient-reported outcome among kidney transplant 
recipients (KTRs), occurring in up to 59% of these patients (3-5) and substantially impacting 
upon quality of life (QoL) (4, 5).  Yet it is often medically unexplained, clinically under-
recognised, and usually untreated (4).   
 
One of the most frequently used instruments for fatigue assessment, namely Multi-
Dimensional Fatigue Inventory-20 (MFI-20), measures physical, behavioural, emotional and 
cognitive components contributing to the overall assessment of fatigue.  Although KTRs 
displayed high scores in all aspects of fatigue (4), physical fatigue, found in 38% of KTRs 
(4), represents the dominant component outweighing behavioural, emotional, and cognitive 
aspects (4), and impacts on all domains of QoL (4).   
 
Conceptually, physical fatigue has traditionally been considered as a consequence of 
strenuous physical activity.  Accordingly, excessive physical fatigue may be ascribed to 
either “cardiovascular”, “muscular”, or “perceptual” aetiologies.  The cardiovascular model 
refers to insufficient cardiovascular oxygen or nutrient delivery to the muscular system, 
limiting oxidative phosphorylation and glycolysis, both essential mechanisms for muscle 
contraction (6).  Correspondingly, “cardiovascular” fatigue results in decreased ability of 
muscle to generate and maintain force, contributing to physical fatigue.  The “muscular” 
model denotes insufficient muscle mass or reduced muscular function, leading to failure of 
muscle force generation (6-8), and/or inability to maintain force or power output (9), 
resulting in physical fatigue.  The “perceptual” theory represents increased perception of 
effort, characterised by loss of motivation and reluctance to perform physical tasks when 
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perception of effort reaches a certain level.  In fatigue with perceptual origin, individuals 
experience heightened responses to a combination of feed forward signals from the motor 
centres and afferent feedback from the working body (6, 10, 11), resulting in depressed 
motivation with increasing exercise intensity and/or duration.  The extent of inhibition varies, 
individuals with heightened perceived exertion experiencing a greater sense of effort for a 
given workload, expressed as physical fatigue.  Of interest, it is recognised that mental 
fatigue, characterised by inability to focus and maintain cognitive attention, is a crucial 
determinant of physical limits in healthy individuals (12-14), by heightening the perception 
of exertion (12, 13).   
 
The cardinal mechanisms underlying physical fatigue in KTRs remain unexplored.  The 
primary objectives of this study were to systematically examine the aetiology of physical 
fatigue in KTRs, by measuring factors which may be mechanistically linked to symptoms of 
physical fatigue.  These include quantification of muscle mass, assessment of muscular and 
cardiovascular function, and evaluation of perceived exertion during a standardised exercise 
protocol.  In addition, the incidence of physical fatigue, and its impact on QoL in clinically 
stable KTRs, were examined.  The key findings were that physical fatigue affected 22% of 
clinically stable KTRs, adversely impacted on QoL, and was unrelated to cardiovascular or 
muscular factors.  Rather, heightened perception of fatigue during exercise was closely 
related to physical fatigue.  These findings led to further investigation to examine the role of 
mental fatigue, and other plausible predictors of heightened perception.   
 
Subjects and Methods 
Participants and Study Design 
 Prevalent KTRs were recruited from the renal transplant outpatient clinic at Queen Elizabeth 
Hospital Birmingham UK, between August 2011 and August 2013.  Inclusion and exclusion 
criteria are detailed in Table 1.  Of 67 KTRs approached, 12 did not participate mainly due to 
work commitment.  Age- and gender- matched healthy subjects (control group) were 
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recruited over the same time period, from Queen Elizabeth Hospital Birmingham UK through 
recruitment posters, and from University of Birmingham UK by email invitations to all 
students and staff members.  Of 45 volunteers, 4 were excluded due to the presence of known 
chronic illnesses and the use of regular medications.  
The study was approved by the local research ethics committee, and was conducted in 
accordance with the principles of the Declaration of Helsinki. 
 
Protocol Overview 
 
KTRs and controls attended the research visit in the morning following an overnight rest and 
a light breakfast (260kcal; 12g protein).  Upon arrival, the testing procedures including the 
use of questionnaires, tools and equipment were explained. 
The order of tests was standardised.  First, blood sampling was undertaken.  Self-completion 
of questionnaires, including Multi-Dimensional Fatigue Inventory-20 (MFI-20), Hospital 
Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index (PSQI), and Medical 
Outcomes Study Short-Form 36 (SF-36) followed.  Then, Dual-Energy X-Ray 
Absorptiometry (DEXA) scanning and jumping mechanography were undertaken.  Finally, 
participants rested for one-hour prior to performing an incremental submaximal exercise test, 
which included a measure of exertion using the Borg Rating of Perceived Exertion (RPE) 
scale. 
 
Multi-Dimensional Fatigue Inventory-20 (MFI-20) and Definition of Physical Fatigue 
Severity of physical fatigue was assessed subjectively using the MFI-20, a 20-item self-report 
questionnaire measuring fatigue in 5 dimensions, with 4 items measuring physical fatigue 
using a 5-point Likert scale.  Scores for physical fatigue ranged from 4-20, with higher scores 
indicating greater fatigue.  See Supporting Information, Subjects and Methods. 
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The incidence of physical fatigue was determined using the previously established definition 
of physical fatigue, defined as ≥95th percentile for the general population as reported by Lin 
et al (4, 15). 
 
Dual-Energy X-ray Absorptiometry 
DEXA provided measures of whole-body lean tissue mass (LTM), lower limb lean tissue 
mass (LLTM), and fat mass (FM) (16, 17).  Both LTM and LLTM were normalised to height 
squared (Ht2) accounting for differences in body size.  See Supporting Information, 
Subjects and Methods. 
 
Jumping Mechanography 
The Leonardo Mechanography Ground Reaction Force Platform (Novotec Medical, 
Germany) was used to assess lower limb muscle power, an indication of muscular function.  
Participants performed a two-legged counter movement jump (CMJ) on the platform.  Peak 
power of the vertical movement was computed by the system as the product of force and 
velocity (18-22), then normalised to total body mass (BM).  Jumping mechanography 
predominately investigates kinetic factors of lower limb muscle function (23, 24), peak power 
was also adjusted to LLTM.  See Supporting Information, Subjects and Methods.   
 
Incremental Submaximal Exercise Test 
Cardiovascular function, represented by maximal oxygen consumption (VO2max) and 
oxygen pulse (O2 pulse), were measured by performing a submaximal incremental exercise 
test on an electrically braked cycle ergometer (Lode Corival, Cranlea, UK). 
 
The exercise protocol was preceded and followed by two-minute warm-up and cool-down 
periods at 10 watts (W).  The test started at 25W, with work rate increasing by 25W at three-
minute intervals until voluntary exhaustion or the end of three-minute at 75W.  Participants 
were encouraged verbally to maintain cadence ≥65 revolutions per minute. 
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Expired air volume and composition were collected continuously and analysed every 30 
seconds using the MOXUS Modular Metabolic System (AET Technologies, USA), providing 
oxygen consumption (VO2).  See Supporting Information, Subjects and Methods.  Heart 
rate (HR) was monitored continuously and recorded every 30 seconds (Polar Vantage, 
Finland). 
 
The VO2 and HR measurements were averaged over the final minute of each three-minute 
workloads (25W, 50W and 75W).  Consequently, VO2max was estimated by linear 
regression of VO2 as a function of HR, and extrapolating VO2 to age-predicted maximum 
HR:  Age-predicted maximum HR = 205.8–(0.685×Age) (25-27).  Estimated VO2max 
correlates highly with measured VO2max when calculated with this approach (28).  An 
example of the linear regression is shown in Figure 1a; the mean r2 for the linear regression 
in the studied cohort was 0.97 ± 0.04.  
 
O2 pulse, oxygen consumed per heartbeat, was calculated as the gradient of the linear 
regression of VO2 versus HR (29).  An example is shown in Figure 1b; the mean r2 for the 
cohort was 0.97 ± 0.05.  O2 pulse was expressed as absolute volume and adjusted for BM.  To 
account for the effect of body size on O2 pulse during exercise, O2 pulse was also adjusted to 
LTM. 
 
Perception of Exertion 
Perception of exertion was evaluated using the 15-point Borg RPE Scale (28).  This is a self-
reported measure that evaluates the subjective perception of exertion on a scale of 6-20, with 
6 representing “no exertion at all”, and 20 denoting “maximal exertion”.  The RPE Scale was 
administered using standardised instructions provided by Borg (30).  Participants were 
familiarised with the scale prior to exercise testing.  Although subjects received strong 
concurrent verbal encouragement throughout the exercise protocol, memory anchoring was 
not used.  The RPE scale was displayed in sight of the participant during the entire exercise.  
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In the last 5 seconds of each minute of the exercise, participants reported an instantaneous 
RPE by pointing at the scale. 
To account for inter-individual differences in predicted maximum HR due to variations in 
age, a Rating of Perceived Exertion “Index” (RPEindex) was adopted for both within-group 
and between-group comparisons.  To derive RPEindex, the actual RPE at the end of the 
exercise protocol (or volitional fatigue) was compared to the expected RPE based on the 
subject’s HR at that time as a fraction of estimated age-predicted maximum HR and 
assuming that RPE would be 20 at maximum HR.  RPEindex is therefore independent of age 
and absolute work rate, and hence a true reflection of the subject’s sense of effort per se.  
Derivation is summarised as follows: 
 
RPEindex = (Actual RPE / Expected RPE of 20) × (Estimated Age-predicted Maximum HR / 
Actual HR at exhaustion or end of exercise) 
As such, a RPEindex of 1.0 is considered “normal”, with values above this representing 
heightened perception of effort during this exercise protocol, and vice versa. 
 
Quality of Life Assessment  
SF-36 was used to assess QoL, consisting of 36 questions grouped into 8 subscales 
corresponding to different life domains.  It generates a total score for QoL, as well as 
physical- and mental- health scores.  Within the SF-36, there is an “energy and vitality” 
subscale that measures fatigue (31).  Due to its confounding effect, correlations with physical 
fatigue were analysed prior to and following exclusion of this subscale.  See Supporting 
Information, Subjects and Methods. 
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Clinical, Demographic, Psychosocial and Behavioural Data Collection  
Blood sampling was undertaken from both KTRs and control group for analysis of high-
sensitivity C-Reactive Protein (hsCRP), haemoglobin (Hb) and creatinine-derived estimated 
Glomerular Filtration Rate (eGFR) using the 4-variable modification of diet in renal disease 
equation (32).     
  
For both KTRs and control group, the following data were enquired by questionnaire:  age, 
gender, marital status, ethnicity, smoking status (never smoked, current smoker, ex-smoker), 
alcohol intake (units per week), symptoms of anxiety and depression assessed using HADS, 
and sleep quality evaluated using PSQI.  See Supporting Information, Subjects and 
Methods. 
 
For KTRs, the following data were collected from patient’s medical records:  time post-
transplantation, co-morbidity assessed as Index of Co-Existing Disease (ICED) (33), presence 
of diabetes, either pre-transplantation (pre-DM) or New Onset Diabetes After Transplantation 
(NODAT), prior acute rejection episodes, beta-adrenergic blocker and immunosuppressive 
medication usage.   
 
Statistical Analysis 
Statistical analyses were performed using SPSS Statistics 21 (Chicago, IL).  Regression 
diagnostics were performed.  Results were presented as mean ± SD for normally distributed 
data, or median (interquartile range; IQR) for non-normal data.  Chi-square or Fisher’s exact 
tests were used to compare differences between groups on categorical variables.  Mann-
Whitney U test was used to compare differences between groups on ordinal variable.  
Independent-sample t-test was used to compare continuous data between groups.   
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Linear regression analysis was used to determine the association between predictor variable 
and the continuously-distributed outcome variable.  There were two outcome variables in this 
study, physical fatigue and RPEindex, and both variables were tested for normality prior to 
regression analyses.  The analyses were performed in three stages.  Initially, the effect of each 
variable was examined in a series of univariate regression analyses.  Then, interaction 
analyses moderated by the effect of gender, age and eGFR for each of the univariate 
relationships were performed.  Subsequently, the joint effect of variables demonstrating some 
evidence of association in univariate analyses (p<0.20) was examined in a multivariate 
regression analysis, using a fully adjusted multivariate model.  A type I error rate ≤5% 
(p≤0.05) was considered significant in the model.  Specifically, the associations between each 
of the cardiovascular parameter and physical fatigue were adjusted for usage of beta-
blockers.   
 
Results 
Population characteristics for the cohorts of KTRs and controls are shown in Table 2.  
Results for physical fatigue score, measurements of muscle mass and function, VO2max, O2 
pulse, and RPEindex for both cohorts are indicated in Table 3.  The comparisons of these 
parameters between KTRs and control group are also shown in Table 3.   
 
Muscular Mass and Function 
Table 3 shows that LTM adjusted to Ht2 and LLTM adjusted to Ht2 did not differ 
significantly between KTRs and controls in either males or females. 
Similarly, Table 3 indicates that jumping power derived from CMJ per kg LLTM did not 
differ significantly between KTRs and controls in either males or females.  However, while 
jumping power from CMJ per kg BM did not differ significantly between female KTRs and 
female controls, it is significantly lower in male KTRs compared to their control 
counterparts.   
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Importantly, in the analysis of KTRs, no correlation was found between physical fatigue and 
LTM adjusted to Ht2 (r=0.09, p=0.75), LLTM adjusted to Ht2 (r=0.05, p=0.48), muscular 
power from CMJ (r=0.18, p=0.33), or CMJ adjusted to BM (r=0.19, p=0.31), or CMJ 
adjusted to LLTM (r=0.24, p=0.28). 
 
Cardiovascular Function 
Table 3 indicates that VO2max, absolute O2 pulse, O2 pulse adjusted to BM, and O2 pulse 
adjusted to LTM were significantly lower in female KTRs compared to female controls.  No 
differences between male KTRs and controls were seen. 
 
Of note, in the analyses relating to KTRs, no significant correlations were seen between 
physical fatigue and VO2max (r=0.23, p=0.09), absolute O2 pulse (r=0.17, p=0.21), O2 pulse 
adjusted for BM (r=0.21, p=0.20), or O2 pulse adjusted for LTM (r=0.17, p=0.23).   
 
Perceived Exertion 
Figure 2 shows the overall distribution of RPEindex in KTRs and the control group.  RPEindex 
was significantly higher in KTRs (1.0±0.3) compared to controls (0.8±0.2) (p=0.001).  
Specifically, as shown in Table 3, RPEindex was significantly higher in both male (0.9 ± 0.3) 
and female (1.0 ± 0.2) KTRs compared to male (0.7 ± 0.2) and female (0.8 ± 0.2) controls 
respectively. 
 
Notably, in the regression analysis pertaining to KTRs, and in contrast to the lack of 
association between physical fatigue and either cardiovascular or muscular parameters, 
RPEindex demonstrated a significant, graded, and positive correlation with physical fatigue 
(r=0.42, p=0.001, Figure 3). 
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Predictors of Physical Fatigue in Kidney Transplant Recipients 
Physical fatigue scores were normally distributed and analysed on the original scale of 
measurement.  Table 4 shows the associations between physical fatigue and measures of 
muscle mass and function, VO2max, O2 pulse, and RPEindex in KTRs.  On univariate analysis, 
the only significant predictor of increasing physical fatigue in KTRs was increased RPEindex 
(β=5.7; 95% Confidence Interval [CI]=2.2, 9.2; r=0.42; p=0.001, Figure 3).  No significant 
associations were seen between physical fatigue and measures of muscle mass and function.  
A trend towards an association between physical fatigue and VO2max was evident on 
univariate analysis (β=-0.1; 95% CI=-0.2, 0.0; r=0.23; p=0.09), Figure 4.  
 
With RPEindex and VO2max analysed in the fully adjusted multivariate model, VO2max no 
longer retained significance (β=-0.1; 95% CI=-0.2, 0.1; p=0.43).  In this model, RPEindex 
remained the single independent predictor of physical fatigue (β=5.4; 95% CI=1.6, 9.3; 
p=0.001).  Of note, no significant age-, gender-, and eGFR- interactions were found between 
physical fatigue and any predictor variables (p>0.05 for all associations), see Supporting 
Information, Results, Table 1. 
 
Incidence of Physical Fatigue; and Correlation with Quality of Life in Kidney 
Transplant Recipients 
As shown in Table 3, the mean score for physical fatigue in KTRs was 10±4, higher than that 
reported by the control group at 6±3 (p<0.001; Figure 5).  Based on the established definition 
of physical fatigue (≥95th percentile for general population) (4, 15), the incidence of physical 
fatigue in KTRs was 22%.  Coincidentally, when the incidence of physical fatigue was 
categorised using ≥95th percentile for the control group, comparable incidence (22%) was 
identified. 
 
 
A
cc
ep
te
d 
A
rt
ic
le
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 3 indicates that SF-36 total, physical and mental health summary scores for KTRs 
were significantly lower than the corresponding scores for the control group.  In KTRs, 
physical fatigue correlated closely with SF-36 total score (r=-0.68; p<0.001), SF-36 physical 
health summary score (r=-0.74; p<0.001), and SF-36 mental health summary score (r=-0.60; 
p<0.001), Figure 6a.   To exclude the confounding effect of the SF-36 “energy and vitality” 
subscale, which is a general measure of fatigue within SF-36 (31), results were reanalysed 
excluding this subscale, and the associations remained comparable after this exclusion [SF-36 
total score r=-0.65 (p<0.001), SF-36 physical health summary score r=-0.71 (p<0.001), and 
SF-36 mental health summary score r=-0.53 (p<0.001); Figure 6b)]. 
 
Predictors of Perceived Exertion in Kidney Transplant Recipients 
Finally, in light of the association between RPEindex and physical fatigue in KTRs, and the 
previously described association between mental fatigue and perceived exertion in a non-
transplant cohort (12), the impact of mental fatigue and other plausible predictors upon 
perceived exertion was examined in this cohort of KTRs. 
 
Scores for RPEindex were normally distributed and analysed on the original scale of 
measurement.  Measurements of the potential predictors of RPEindex, including demographic, 
clinical, nutritional, psychosocial and behavioural parameters are indicated in Tables 2 and 
3.  On univariate analysis, as shown in Table 5, mental fatigue, NODAT, absence of 
cyclosporine, increasing age, low alcohol intake, anxiety, and depression were significantly 
associated with RPEindex.  In the fully adjusted multivariate analysis, age and depression did 
not retain significance, but the remaining variables remained significantly associated with 
RPEindex (Table 5).   
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Discussion 
This is the first study to systematically investigate the potential aetiology of physical fatigue 
in KTRs, and reveals novel findings.  Specifically, physical fatigue in KTRs seems unrelated 
to muscular and cardiovascular factors, but rather, it is driven by increased perception of 
exertion during exercise.  In turn, mental fatigue is significantly associated with such 
heightened perception of effort.  The findings of the current study also confirm physical 
fatigue as a common and disabling symptom among KTRs, negatively impacting on QoL (3-
5).  Whilst novel to transplantation, these results resonate with recent findings emerged from 
other populations, whereby heightened perception limits exercise capacity in healthy trained 
individuals (34) and diabetic patients (35), and mental fatigue impairs physical performance 
in healthy subjects through increased perception of effort rather than limiting 
musculoenergetic or cardiovascular function (12, 13).  In addition, observations in chronic 
fatigue syndrome (CFS) further support the findings from this study, corroborating that 
fatigue is not explained by deficits in the muscular and cardiovascular systems (36).  These 
results suggest that interventions directed towards the psychology rather than physiology of 
fatigue may be beneficial to KTRs with this important and debilitating symptom. 
 
This is a single-centre pilot study of 55 patients, and validation is needed in larger cohorts.  
For ethical and safety reasons, the physiological testing was performed in a selected cohort of 
clinically stable KTRs, limiting the generalisation of the results to the overall kidney 
transplant population.  However, the focus of the current study was to specifically address 
physical fatigue in this context, enabling evaluation without the confounding effect of 
intercurrent or chronic illnesses.  Thus, it is noteworthy that despite this targeted enrolment, 
and based on the established definition of physical fatigue (≥95th percentile for general 
population) (4, 15), 22% of KTRs experienced significant physical fatigue.  Indeed, the mean 
physical fatigue score in KTRs (10±4) was higher than healthy subjects in the control group 
(6±3), and comparable to “chronically unwell” patients (10±4) reported previously by Lin et 
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al (15).  This, together with the adverse associations with all aspects of QoL, indicates the 
severity of the problem. 
 
Varied disease processes, immunosuppression with steroid therapy, and lack of physical 
activity may result in muscle atrophy.  In these circumstances, muscles work at a relatively 
high work-load even in everyday life, and hence fatigue rapidly.  However, whole body LTM 
and LLTM in KTRs were comparable to healthy subjects in the control group, and there was 
no association between physical fatigue with either whole body LTM or LLTM in KTRs.  In 
support of these results, muscle mass was comparable to previous literature in this field (37, 
38).  Certainly, muscle mass per se may not be the crucial factor, the ability of musculature to 
generate force and movement may be of greater importance.  Interestingly, the results from 
the jumping mechanography studies showed that KTRs were mostly capable of generating 
muscular power similar to healthy subjects in the control group, apart from the observation 
that male KTRs displayed significantly lower muscular power adjusted to body weight 
compared to healthy subjects in the control group.  Such discrepancy may be explained by 
significantly higher adiposity measured by DEXA among male KTRs compared to male 
controls.  Nevertheless, there were no associations between any measure of muscular power 
and physical fatigue among KTRs. 
 
VO2max is the conventional measure of cardiovascular fitness, and its prognostic utility is 
well-established in research and clinical settings (39, 40).  In this study, VO2max was 
estimated by extrapolating oxygen uptake from the relationship with HR during a 
submaximal exercise test.  This is a common approach (27), although there are 2 caveats.  
Firstly, estimation of maximum HR in relation to age can be unreliable (25, 41).  Secondly, 
the conventional expression of body weight-adjusted VO2max may be misleading due to 
inter-individuals’ variability in body composition.  Accordingly, fat mass may influence 
VO2max measurement that has limited relevance to actual cardiovascular function.  An 
alternative, but complimentary measure of O2 pulse has recently emerged (39, 40).  O2 pulse 
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is independent of body composition and maximum HR, and predominately determined by 
cardiac stroke volume and peripheral oxygen extraction during exercise, thereby potentially 
reflecting cardiovascular function more accurately (39, 40, 42).  Both male and female KTRs 
had numerically lower VO2max and O2 pulse measures compared to healthy subjects in the 
control group, albeit only of statistical significance in females.  In support of these results, 
VO2max data was comparable to findings from previous studies in this field (37, 38, 43, 44).  
Of note, neither VO2max nor O2 pulse were associated with physical fatigue in KTRs in the 
adjusted multivariate analysis.  The difference in cardiovascular fitness between KTRs and 
healthy subjects is perhaps unsurprising, but identifying the underlying reasons for this was 
not the focus of the current study.   
 
In contrast, it was RPEindex that independently and significantly correlated with physical 
fatigue in KTRs, consistent with a heightened perception of exertion.  It should be noted that 
this derived index takes into account predicted maximal HR, and is therefore not a reflection 
of age, cardiovascular fitness and absolute work rate.  The RPEindex represents an objective 
evaluation of perceived exertion during a protocolled exercise test.  In the absence of 
evidence that cardiovascular or muscular mechanisms were associated with physical fatigue, 
the results of this study suggest that modifying the perception of fatigue may be the key to 
alleviate this symptom. 
     
The mechanisms by which perception of effort influences physical performance has been 
proposed by Marcora and colleagues using the Brehm’s theory of motivation (12).  In this 
theory, individuals opt to withdraw from a task when it is perceived to be too difficult, or the 
effort required exceeds the individuals’ willingness to perform (45).  During the decision-
making process, individuals are suspected to have lowered their level of task difficulty for 
withdrawal (46, 47), and indeed, impaired physical performance is a common feature in 
KTRs (48, 49). 
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In turn, KTRs displayed considerable mental fatigue, with MFI-20 scores of 10±5, 
comparable to “chronically unwell” patients (11±4) reported by Lin et al (15).  Further, 
mental fatigue was an independent predictor of increased perception of exertion.  This novel 
finding in KTRs is highly reminiscent of that from Marcora et al in a non-transplant cohort 
(12), whereby experimentally-induced mental fatigue decreases physical performance via 
increased perception of effort, without affecting conventional physiological variables such as 
stroke volume, oxygen uptake, blood pressure, or lactate levels (12).  In addition, it has been 
shown that experimentally-induced mental fatigue does not affect neuromuscular function 
(13), suggesting a failure of central motivation driving physical fatigue.  Mental fatigue was 
measured by self-report questionnaire in this study, whereas mental fatigue was induced 
experimentally by a 90-minute computer-based cognitive task in Marcora’s study (12), hence 
it is unclear whether the two methodologies characterised equivalent effects.  Yet the 
similarities between the studies are noteworthy, and it is highly plausible that increased 
perception of exertion results from mental fatigue among KTRs, contributing to symptoms of 
physical fatigue. 
 
In this study, the mean anxiety score for KTRs on HADS was 8±5, considered as mild 
anxiety (50).  Increased anxiety was independently associated with heightened perceived 
exertion.  Depression also displayed a univariate association with increased perceived 
exertion.  These observations were noted in previous studies of non-transplant cohorts (51, 
52), highlighting the relevance of the current findings.  However, a caveat with the 
interpretation of the associations between self-reported data should be acknowledged, known 
as “common method variance” (53).  This includes symptoms of physical and mental fatigue, 
perceived exertion, anxiety and depression, whereby patients in negative mood perceive, 
remember, and report more physical and psychological symptoms, and report those 
symptoms to be more severe than patients with less negative mood (54).  Dissecting the 
differences between the self-reported symptoms of “psychological distress” requires detailed 
psychological evaluation, and such evaluation was beyond the scope of the current study.  
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Nevertheless, the findings of the current study point towards psychological factors rather than 
physiological underperformance as the drivers of physical fatigue in KTRs.  Future studies 
should focus on testing interventional strategies aiming to improve psychological factors.  
Exercise intervention, cognitive behavioural therapy (CBT) and centrally-acting 
pharmacological therapy may be beneficial in this setting.  Exercise-based interventions have 
shown promising results in relieving anxiety and depressive symptoms (55, 56), and may 
indirectly improve perception of fatigue.  Exercise therapy has also demonstrated efficacy in 
alleviating symptoms of fatigue in CFS (57).  A recent pre-clinical study showed that 
exercise training increases brain mitochondrial biogenesis, contributing to reductions in 
centrally-mediated fatigue (58).  The exact mechanisms for these changes are unknown, but it 
is possible that increased brain mitochondria plays an important role in reducing fatigue 
through their influence on cerebral energy status (58).  CBT per se or with exercise 
integration were found effective in treating symptoms of fatigue and mood in somatoform 
disorders, CFS, or fibromyalgia (59-61), and such approaches may be applicable in this 
setting.  The use of centrally-acting pharmacological therapy may also be considered.  
Selective serotonin reuptake inhibitors (SSRI) are used in patients with marked fatigue 
resulting from significant anxiety (62), and they reduce fatigue in depressed patients with 
multiple sclerosis through positive effects on mood (63).   
 
The commonly studied clinical and demographic variables, including eGFR, Hb and hsCRP, 
showed no associations with perception of effort in KTRs.  Other factors which were 
associated with heightened perceived exertion in KTRs included NODAT, absence of 
cyclosporine, and low alcohol intake.  These correlations may be biologically plausible (64-
69), although the possibility of type I statistical error should be acknowledged. 
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In conclusion, it is likely that improving physical fitness or function per se may not improve 
physical fatigue, and other strategies such as exercise interventions, cognitive behavioural 
therapy or centrally-acting pharmacological therapies may be more appropriate.  The findings 
of this study set the scene for future interventional research and therapeutic strategies. 
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Potential Predictors of Physical Fatigue in Kidney Transplant Recipients 
(KTRs) and Healthy Subjects (Control Group) 
Table 4.   Predictors for Mechanistic Aetiology of Physical Fatigue in Kidney 
Transplant Recipients (KTRs) 
Table 5.   Predictors of Rating of Perceived Exertion Index (RPEindex) in Kidney 
Transplant Recipients (KTRs) 
 
 
Table 1.  Inclusion and Exclusion Criteria 
Inclusion Criteria 
 KTRs beyond 1 year post-transplantation 
 Stable graft function (<10% increase in serum creatinine 
over the preceding 6 months) 
Exclusion Criteria 
 Inability to provide written informed consent 
 Episodes of acute rejection within the last 6 months  
 Evidence of sepsis in the last 6 weeks 
 Known active malignancy or chronic infection 
 History of thyroid disease of adrenal insufficiency 
 Evidence of unstable angina (occurring at rest, severe and of 
new onset, or crescendo pattern) 
 Evidence of acute coronary syndrome in the last 6 months 
 Moderate or severe aortic stenosis (mean transvalvular 
gradient of >25mmHg or valve area of <1.5cm2 on echocardiogram) 
 Immobility 
 Pregnancy 
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Table 2.  Population Characteristics for Kidney Transplant Recipients (KTRs) and 
Healthy Subjects (Control Group) 
 
Demographic parameters KTRs
 
Control Group P-value
Sample size 
 
n = 55 n = 41 
 
n/a 
Gender (%) 
 
Male = 57 
Female = 43 
 
Male = 56 
Female = 44 
1.00 a 
†Mean age (years) 
 
46 ± 14  48 ± 12 0.94b 
Marital status (%) 
 
Single = 22 
Married = 67 
Divorced/Widowed = 11 
 
Single = 20 
Married = 68 
Divorced/Widowed = 12 
0.95c 
Ethnicity (%) 
 
Caucasian = 80 
Asian = 13 
Afro-Caribbean = 5 
Others = 2 
 
Caucasian = 82 
Asian = 12 
Afro-Caribbean = 6 
Others = 0 
 
1.00 a,d 
‡Median time post-transplantation (years) 
 
2 (1-7) n/a n/a 
Co-morbidity and clinical parameters KTRs 
 
Control Group P-value 
‡Median ICED 2 (2-2) 
 
n/a n/a 
Presence of diabetes (%) 
 
Non-diabetic = 73 
NODAT = 14 
Pre-DM = 13 
Non-diabetic = 100 
NODAT = n/a 
Pre-DM = n/a 
n/a 
n/a 
n/a 
Previous episodes of acute rejection (%) 
 
7 n/a n/a 
Use of beta-adrenergic blocker (%) 
 
4 0 n/a 
Immunosuppressive medication usage: 
Calcineurin inhibitor (%) 
Adjunctive antiproliferative agent (%) 
Prednisolone (%) 
 
 
93 
87 
86 
 
 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
Dosage of immunosuppressive medications: 
†Mean dose of tacrolimus (mg/day) 
†Mean dose of cyclosporine (mg/day) 
†Mean dose of mycophenolate mofetil (mg/day) 
†Mean dose of azathioprine (mg/day) 
‡Median dose of prednisolone (mg/day) 
 
 
5.8 ± 3.2 
184 ± 47 
1147 ± 456 
85 ± 36 
5.3 (5.0-5.0) 
 
n/a 
n/a 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
n/a 
n/a 
Psychosocial & behavioural parameters 
 
KTRs Control Group P-value 
Smoking status (%) Non-smoker = 60 
Current smoker = 11 
Ex-smoker = 29 
 
Non-smoker = 62 
Current smoker = 8 
Ex-smoker = 30 
 
0.83c 
‡Median alcohol intake (units/week) 
 
2 (0-3) 3 (1-4) 0.32b 
†Mean anxiety score (HADS score) 
 
8 ± 5 4 ± 3 0.002e 
‡Median depression score (HADS score) 
 
4 (1-6) 2 (1-3) 0.004e 
†Mean sleep quality score (PSQI global score) 
 
6 ± 3 4 ± 3 0.001e 
Biochemical profile 
 
KTRs Control Group P-value 
‡Median hsCRP (mg/l) 
 
1.67 (0.61-3.96) 0.92 (0.49-2.14) 0.01b 
†Mean Hb (g/dl) 
 
12.6 ± 1.5 14.0 ± 1.4 0.17b 
†Mean eGFR (ml/min) 
 
49.4 ± 12.9 82.2 ± 11.7 <0.001b 
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Table 3.  Measurements of Physical and Mental Fatigue, Quality of Life, and Potential Predictors of Physical Fatigue in Kidney Transplant Recipients 
(KTRs) and Healthy Subjects (Control Group) 
 
 
Physical fatigue KTRs Control Group P-value 
†Mean MFI-20 score 
MFI-20 score ≥95th percentile for general population* (%) 
10 ± 4 
22 
6 ± 3 
3 
<0.001a 
0.006a 
Mental fatigue  KTRs Control Group P-value 
†Mean MFI-20 score 
MFI-20 score ≥95th percentile for general population* (%) 
10 ± 5 
20 
7 ± 3 
5 
0.78a 
0.18a 
Quality of Life KTRs Control Group P-value 
†Mean total score 
†Mean physical health summary score 
†Mean mental health summary score 
77 ± 18 
73 ± 20 
77 ± 18 
88 ± 10 
85 ± 11 
87 ± 9 
0.01a 
<0.001a 
0.03a 
Body composition (DEXA measurements) KTRs Control Group P-value 
All Male Female All Male Female All Male Female 
†Mean LTM (kg) 
†Mean LTM adjusted to Ht2 (kg/m2) 
†Mean LLTM (kg) 
†Mean LLTM adjusted to Ht2 (kg/m2) 
†Mean FM (kg) 
50.7 ± 11.5 
17.5 ± 2.5 
16.0 ± 3.7 
5.5 ± 0.9 
26.1 ± 2.4 
58.0 ± 9.6 
18.7 ± 2.4 
18.1 ± 3.1 
5.8 ± 0.8 
25.9 ± 2.3 
41.2 ± 4.9 
15.8 ± 1.6 
13.4 ± 2.4 
5.0 ± 0.8 
26.1 ± 2.6 
52.3 ± 9.7 
17.8 ± 2.3 
17.0 ± 3.1 
5.7 ± 0.9 
24.0 ± 2.1 
57.9 ± 7.4 
18.6 ± 1.7 
18.8 ± 2.6 
6.1 ± 0.7 
22.9 ± 2.1 
44.8 ± 7.0 
16.7 ± 2.6 
14.4 ± 3.0 
5.4 ± 1.1 
24.9 ± 2.2 
0.11b 
0.63b 
0.21b 
0.22b 
0.26b 
0.31b 
0.81b 
0.78b 
0.22b 
0.04b 
0.11b 
0.18b 
0.19b 
0.21b 
0.67b 
Jumping mechanography KTRs Control Group P-value 
All Male Female All Male Female All Male Female 
†Mean muscle power from CMJ (W) 
†Mean muscle power per BM from CMJ (W/kg) 
†Mean muscle power per LLTM from CMJ (W/kg) 
2641 ± 756 
35 ± 7 
169 ± 31         
3008 ± 727 
37 ± 8 
172 ± 33 
2171 ± 493 
32 ± 6 
166 ± 29 
2962 ± 727 
40 ± 7 
170 ± 30 
3567 ± 745 
47 ± 6 
177 ± 25 
2397 ± 523 
36 ± 7 
160 ± 30 
0.12b 
0.10b 
0.45b 
0.06b 
0.03b 
0.42b 
0.31b 
0.25b 
0.41b 
 
Incremental submaximal exercise test KTRs Control Group P-value 
All Male Female  All Male Female All Male Female  
†Mean VO2max (ml/min/kg) †Mean O2 Pulse (ml/beat) †Mean O2 Pulse (ml/beat/kg BM) 
†Mean O2 Pulse (ml/beat/kg LTM) 
27.7 ± 10.4 
16.8 ± 5.8 
0.22 ± 0.07 
0.35 ± 0.14 
31.1 ± 10.7 
21.6 ± 7.4 
0.26 ± 0.08 
0.38 ± 0.13 
22.4 ± 5.5 
12.0 ± 4.2 
0.18 ± 0.06 
0.30 ± 0.14 
30.2 ± 8.1 
20.1 ± 5.4 
0.26 ± 0.07 
0.40 ± 0.08 
35.0 ± 8.2 
24.5 ± 5.5 
0.30 ± 0.06 
0.42 ± 0.07 
27.2 ± 6.7 
17.2 ± 5.5 
0.24 ± 0.07 
0.38 ± 0.09 
0.13b 
0.18b 
0.20b 
0.22b 
0.15b 
0.26b 
0.21b 
0.29b 
0.02b 
0.03b 
0.04b 
<0.001b 
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Borg scale KTRs Control Group P-value 
All Male Female All Male Female All Male Female 
†Mean RPEindex 1.0 ± 0.3         0.9 ± 0.3 1.0 ± 0.2 0.8 ± 0.2 0.7 ± 0.2 0.8 ± 0.2 0.001b 0.001b 0.002b 
 
†Normally distributed data, results expressed as mean ± standard deviation (SD).  *Established definition of physical fatigue:  ≥95th percentile for general population reported by Lin et al (4, 15). 
aMann-Whitney U test was used to test statistical differences between 2 groups on the ordinal variable.  bIndependent sample t-test was used to test statistical differences between 2 groups on the continuous variable. 
Abbreviations:  MFI-20=multi-dimensional fatigue inventory-20; DEXA=dual energy x-ray absorptiometry; LTM=lean tissue mass; Ht2=height squared; LLTM=lower limb lean tissue mass; FM=fat mass; CMJ=single two-legged counter movement jump; BM=total body mass; VO2max=estimated maximal oxygen 
consumption; O2 pulse =oxygen pulse; RPEindex=rating of perceived exertion index. 
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Table 4.  Predictors for Mechanistic Aetiology of Physical Fatigue in Kidney Transplant 
Recipients (KTRs) 
 Univariate Analysis Multivariate analysis* 
Beta Coefficient, β 
(95% CI**) 
p-value Beta Coefficient, β 
(95% CI**) 
p-value 
RPEindex 
 
5.7 (2.2, 9.2) 0.001 5.4 (1.6, 9.3) 0.001 
VO2max (ml/min/kg) 
 
***-0.1 (-0.2, 0.0) 0.09 -0.1 (-0.2, 0.1) 0.43 
O2 Pulse (ml/beat) 
 
***3.5 (-4.1, 11.2) 0.21
O2 Pulse (ml/beat/kg BM) 
 
***2.5 (-2.7, 11.4) 0.20
O2 Pulse (ml/beat/kg LTM) 
 
***4.7 (-3.1, 12.6) 0.23   
LTM adjusted to Ht2 (kg/m2) 
 
0.1 (-0.4, 0.5) 0.75   
LLTM adjusted to Ht2 (kg/m2) 
 
-0.4 (-1.6, 0.8) 0.48   
‡CMJ, absolute power (W) 
 
-0.1 (-0.2, 0.1) 0.33   
†CMJ, power per BM (W/kg) 
 
-0.1 (-0.2, 0.1) 0.31
†CMJ, power per LLTM (W/kg) 
 
-0.1 (-0.3, 0.1) 0.28
R2 value from the fully adjusted multivariate model 28%
 
*Results in the fully adjusted multivariate regression model were presented.   
**CI = Confidence Interval. 
***Association adjusted for usage of beta-blockers. 
†Coefficients reported for a 10-unit increase in explanatory variable. 
‡Coefficients reported for a 100-unit increase in explanatory variable. 
Abbreviations:  RPEindex=rating of perceived exertion index; VO2max=estimated maximal oxygen 
consumption; O2 pulse=oxygen pulse; BM=total body mass; LTM=lean tissue mass; Ht2=height squared; 
LLTM=lower limb lean tissue mass; CMJ=single two-legged counter movement jump. 
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Table 5.  Predictors of Rating of Perceived Exertion Index (RPEindex) in Kidney 
Transplant Recipients (KTRs) 
 Univariate Analysis Multivariate Analysis* 
Beta 
Coefficient, β 
(95% CI**) 
p-value Beta 
Coefficient, β 
(95% CI**) 
p-value 
Presence of diabetes 
Non-diabetic 
NODAT 
Pre-DM 
 
0 
0.3 (0.0, 0.5) 
0.6 (-0.2, 1.4) 
 
0.02 
 
0 
0.2 (0.0, 0.5) 
0.2 (-0.0, 0.5) 
 
0.04 
Use of calcineurin inhibitor 
None 
Cyclosporine 
Tacrolimus 
 
0 
-0.3 (-0.5, -0.1) 
-0.1 (-0.3, 0.2) 
 
0.03 
 
0 
-0.4 (-0.6, -0.2) 
-0.0 (-0.3, 0.3) 
 
0.03 
†Mental fatigue (MFI-20 score) 0.3 (0.1, 0.5) 0.04 0.5 (0.1, 0.9) 0.03 
†Anxiety (HADS score) 0.5 (0.1, 0.8) 0.04 0.4 (0.1, 0.7) 0.04 
†Alcohol intake (units per week) -0.4 (-1.1, -0.0) 0.04 -0.6 (-1.1, -0.1) 0.03
†Age (years)  0.1 (0.0, 0.2) 0.04 0.1 (-0.1, 0.2) 0.21 
†Depression (HADS score) 0.5 (0.0, 0.1) 0.05 0.1 (-0.2, 0.5) 0.37 
Use of prednisolone 
No 
Yes 
 
0 
-0.4 (-0.9, 0.1) 
 
0.10 
 
0 
-0.1 (-0.3, 0.1) 
 
 
0.25 
Co-morbidity (ICED score) 0.9 (-0.4, 2.2) 0.18 0.1 (-0.5, 0.6) 0.35 
Previous episodes of acute rejection 
No 
Yes 
 
0 
-0.4 (-1.1, 0.2) 
 
0.20 
  
Time post transplantation (years)  0.1 (-0.2, 0.4) 0.35   
Marital status 
Married 
Single 
Divorced / Widowed 
 
0 
0.2 (-0.6, 0.2) 
-0.0 (-0.2, 0.1) 
 
0.46 
  
***Ethnicity 
Caucasian 
†Non-Caucasian 
 
0 
0.4 (-0.2, 3.8) 
 
0.48 
  
Gender 
Female 
Male 
 
0 
0.1 (-0.2, 0.5)
 
0.51 
  
†FM (kg) 0.1 (-0.2, 0.3) 0.55   
Smoking status 
Never smoked 
†Ex-smoker 
Current smoker 
 
0 
0.5 (-1.6, 2.4) 
0.1 (-7.3, 7.6) 
 
0.66 
  
†Hb (g/dL) 0.3 (-0.9, 1.5) 0.66
†PSQI (global score) 0.1 (-0.5, 0.6) 0.77   
†eGFR (mL/min) 0.0 (-0.1, 0.2) 0.82   
ℓhsCRP (mg/L) 0.0 (-0.3, 0.4) 0.94   
Use of adjunctive antiproliferative agents 
None 
†Mycophenolate mofetil 
Azathioprine 
 
0 
-0.2 (-4.3, 0.4) 
0.0 (-0.3, 0.3) 
 
 
0.98 
  
†LTM (kg) 0.00 (-0.2, 0.2) 0.99   
R2 value from the fully adjusted multivariate model 38% 
*Results in the fully adjusted multivariate regression model were presented.   
**CI = Confidence Interval.   
***For the purpose of statistical analysis, the ethnicity of patients classified as “Afro-Caribbean”, “Asian” and “Others” was 
grouped as “Non-Caucasian”, 80% “Caucasian” versus 20% “Non-Caucasian”. 
†Coefficients reported for a 10-unit increase in explanatory variable.  ℓVariable analysed on the log scale (base 10). 
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Abbreviations:  NODAT=new onset diabetes after transplantation; Pre-DM=pre-existing diabetes mellitus; MFI-20=multi-
dimensional fatigue inventory-20; HADS=hospital anxiety and depression scale; ICED=index of co-existing disease; FM=fat 
mass; Hb=haemoglobin; PSQI=Pittsburgh sleep quality index; eGFR=estimated glomerular filtration rate; hsCRP=high-
sensitivity C-reactive protein; LTM=lean tissue mass. 
 
 
Figure Legends 
 
Figure 1a: An Example of Linear Regression for Estimation of Maximal Oxygen 
Consumption (VO2max) 
Figure 1b: An Example of Linear Regression for Estimation of Oxygen Pulse (O2 
Pulse) 
Figure 2: Comparison of Rating of Perceived Exertion Index (RPEindex) between 
Healthy Subjects (Control Group) and Kidney Transplant Recipients 
(KTRs) 
Figure 3:  Association between Physical Fatigue and Rating of Perceived Exertion 
Index (RPEindex) in Kidney Transplant Recipients (KTRs) 
Figure 4: Association between Physical Fatigue and Maximal Oxygen Consumption 
(VO2max) in Kidney Transplant Recipients (KTRs) 
Figure 5: Comparison of Physical Fatigue Scores between Healthy Subjects (Control 
Group) and Kidney Transplant Recipients (KTRs) 
Figure 6a: 
 
Association between Physical Fatigue and Quality of Life (QoL) in Kidney 
Transplant Recipients (KTRs) ~ All Subscales 
Figure 6b:  Association between Physical Fatigue and Quality of Life (QoL) in Kidney 
Transplant Recipients (KTRs) ~ Excluding “Energy & Vitality” Subscale 
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